STACKD Research is educational—not medical advice. Disclaimer
Also known as: Body Protection Compound-157 · PL 14736
A synthetic peptide fragment derived from a gastric protein, widely discussed for soft-tissue recovery. Human evidence remains limited relative to its online popularity.
Preclinical work explores effects on angiogenesis, nitric oxide pathways, and tissue healing signals. Precise human mechanisms are not settled.
Animal and in-vitro studies report wound-healing and gut-protection signals. Fitness communities extrapolate to tendon, ligament, and gut recovery—those extrapolations outpace high-quality human trials.
Limited rigorous human RCTs for athletic injuries. Quality, purity, and legality of research chemicals vary. Unknown long-term safety profile in healthy athletes.
Start with our in-house roundups—plain-language synthesis of the research, with primary sources cited at the bottom of each.
Secondary citations for verification. Prefer the STACKD summary above for context before opening these.
2011 · review
Review summarizing preclinical GI and healing literature.
2014 · review
Discusses angiogenesis-related findings in preclinical models.
Commonly discussed together
Online communities often discuss GHK-Cu, BPC-157, and TB-500 together under the informal name “GLOW,” usually in the context of skin quality and soft-tissue recovery conversations—not as a single studied product.
GLOW is a community nickname, not a validated clinical protocol. There are no dose schedules here. Read each peptide’s evidence level and primary sources separately.
Skin / repair · Recovery
Commonly discussed together
BPC-157 and TB-500 are frequently mentioned side-by-side in recovery forums as a “commonly discussed together” pairing for soft-tissue talk—again as folklore adjacency, not a packaged regimen.
Preclinical literature for each compound does not equal a combined human protocol. No timelines or doses are provided on STACKD Research.
Recovery